Geschäft · 18.12.20131 Min. Lesezeit
Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) (the Agencies) are announcing the extension of the "Pilot Program for Parallel Review of Medical Products." The Agencies have decided to continue the program as currently designed for an additional period of 2 years from the date of publication of this notice.